TY  - JOUR
AU  - Perez-Medina, Carlos
AU  - Abdel-Atti, Dalya
AU  - Tang, Jun
AU  - Zhao, Yiming
AU  - Fayad, Zahi A
AU  - Lewis, Jason S.
AU  - Mulder, Willem J M
AU  - Reiner, Thomas
PY  - 2016
DO  - 10.1038/ncomms11838
SN  - 2041-1723
UR  - http://hdl.handle.net/20.500.12105/5227
AB  - The application of nanoparticle drug formulations, such as nanoliposomal doxorubicin (Doxil), is increasingly integrated in clinical cancer care. Despite nanomedicine's remarkable potential and growth over the last three decades, its clinical benefits...
LA  - eng
PB  - Nature Publishing Group
KW  - PEGYLATED LIPOSOMAL DOXORUBICIN
KW  - METASTATIC BREAST-CANCER
KW  - NAB-PACLITAXEL
KW  - OVARIAN-CANCER
KW  - DRUG-DELIVERY
KW  - TUMOR
KW  - NANOMEDICINES
KW  - MANAGEMENT
KW  - ONCOLOGY
KW  - IMPACT
TI  - Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
TY  - journal article
ER  -